MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Transcranial sonography and cognitive dysfunction in Parkinson’s disease

    S. Behnke, A. Pilotto, I. Liepelt-Scarfone, R. Yilmaz, C. Pausch, S. Dieterich, I. Posner, J. Spiegel, U. Dillmann, M. Unger, B. Schmidl, J. Bürmann, K. Fassbender, D. Berg (Homburg Saar, Germany)

    Objective: To evaluate the role of transcranial sonography (TCS) in discriminating between Parkinson's disease (PD) patients with normal cognition (PDNC), mild cognitive impairment (PD-MCI) and…
  • 2016 International Congress

    Cognition and amyloid biomarker status in non-demented patients with Parkinson’s disease patients (PD) with or without subjective cognitive decline (SCD)

    I. Liepelt-Scarfone, F. Klumpp, W. Maetzler, S. Nussbaum, M. Timmers, G. Salvadore, M. Albers, K. Michaelis, Z. Tkaczynska, J. Streffer, D. Berg (Tübingen, Germany)

    Objective: To compare the cognitive and Amyloid-beta 1-42 profile of non-demented Parkinson's disease patients (PD) reporting subjective cognitive decline (SCD) with or without concerns regarding…
  • 2016 International Congress

    Construct validity of Moca test in a sample of patients with Parkinson´s disease in Bogotá and Cali – Colombia

    B.E. Muñoz, O. Bernal, A. Castillo, J.L. Orozco (Cali, Colombia)

    Objective: To evaluate of construct validity for a sample of patients with PD in Bogotá and Cali - Colombia. Background: Parkinson´s disease (PD) is a…
  • 2016 International Congress

    Fractionating apathy – Effort, reward and impulsivity mechanisms in Parkinson’s and Huntington’s disease

    C. O'Callaghan, S. Mason, C. Williams-Gray, R. Barker, B. Sahakian, T. Robbins (Cambridge, United Kingdom)

    Objective: Refine understanding of the processes underpinning apathy in neurodegenerative disease, by identifying 1) objective measures to assess apathy; 2) parcellating the broad construct of…
  • 2016 International Congress

    Viewer responses to a virtual reality simulation of Parkinson’s disease psychosis

    J.G. Goldman, G.T. Stebbins, D. Fredericks, M. Upchurch (Chicago, IL, USA)

    Objective: To examine the accuracy, effectiveness, and utility of a novel virtual reality (VR) simulation representing symptoms of Parkinson's disease psychosis (PDP). Background: Diagnosing PDP…
  • 2016 International Congress

    Standardized assessment of camptocormia in idiopathic Parkinson’s disease

    T. Schmidt, G. Ebersbach, G. Doreen (Beelitz-Heilstätten, Germany)

    Objective: The present study aimed to develop a clinical algorithm to comprehensively characterize CC in PD. Background: Clinical assessment of Camptocormia (CC) in Parkinson's disease…
  • 2016 International Congress

    Comparative analysis of upper limb motor function and articulation disorder in Parkinson’s disease

    E. Ruzicka, J. Rusz, T. Tykalova, K. Zarubova, R. Krupicka, R. Jech (Prague, Czech Republic)

    Objective: To assess the relationship between upper limb bradykinesia and hypokinetic dysarthria in Parkinson's disease (PD) using instrumental investigations of speech and limb motor function.…
  • 2016 International Congress

    Freezing of gait in extrapontine myelinolysis

    Y.N. Kwon, D. Lee, T.B. Ahn (Jindo-gun, Korea)

    Background: Extrapontine myelinolysis (EPM) is rarely complicated with akinetic-rigid parkinsonism. Herein we report a case with EPM presenting with freezing of gait (FOG). Methods: Case…
  • 2016 International Congress

    Validation of the Hebrew version of the International Parkinson and Movement Disorder Society—unified Parkinson’s disease rating scale (MDS-UPDRS)

    J. Zitser, A. Bar David, H. Shabtai, A. Ezra, M. Brozgol, C. Peretz, A. Rozenberg, T. Herman, G.T. Setbbins, C.G. Goetz, B.C. Tilley, S.T. Luo, L. Wang, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To assess the clinimetric properties of the Hebrew version of the MDS-UPDRS. Background: The Unified Parkinson's disease Rating Scale (UPDRS) is a rating scale…
  • 2016 International Congress

    Dystonia-deafness syndrome caused by beta -actin gene mutation and the effect of pallidal deep brain stimulation

    H. Eggink, M.E. van Egmond, M.C. Schönherr, C.C. Verschuuren-Bemelmans, T.J. de Koning, M.J.C. van Dijk, M.A.J. Tijssen (Groningen, Netherlands)

    Objective: To report on two patients with dystonia-deafness syndrome associated with a mutation in the beta actin gene and a positive effect of pallidal deep…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley